Most doctors agree Truvada is a boon in AIDS prevention; others express concern. July 16, 2012— -- The Food and Drug Adminstration today announced the approval of the first drug for use in people ...

The rising cost of Gilead’s Truvada may be a key factor in why the HIV prevention drug has not been widely used, according to an analysis published in the Annals of Internal Medicine. Truvada, also ...

When its U.S. patent cliff for HIV med Truvada was still on the horizon, Gilead Sciences won approval for follow-up med Descovy and launched an aggressive campaign to switch patients to the new drug.

Descovy demonstrated continued noninferiority to Truvada for HIV pre-exposure prophylaxis and statistically significant differences over Truvada for pre-specified secondary end points. In the phase 3, ...

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq:GILD) announced today that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) ...

COLUMBUS (WCMH) — Life saving for those living with HIV, disease preventing for those at high risk for contracting it, a dual use drug that both treats and prevents HIV is at the center of multiple ...

Consumer Reports has no financial relationship with advertisers on this site. About 38,000 Americans develop HIV each year, according to the Centers for Disease Control and Prevention. Two ...

Bracing for generics to big-selling HIV prevention drug Truvada, Gilead Sciences is working to switch patients to its new option, Descovy. But the new med's additional benefits aren't worth the huge ...

A major health insurer has notified policy holders that it will no longer cover Gilead Sciences’ drug Descovy for pre-exposure prophylaxis, or PrEP, and will instead require them to switch to Truvada, ...

Editor’s Note: This is the second part of a two-part series on PrEP. Ask a group of gay men what they think of Truvada, and you’re likely to get a response that goes something like this: “I don’t like ...

This post is part of Outward, Slate’s home for coverage of LGBTQ life, thought, and culture. Read more here. In October, the U.S. Food and Drug Administration approved the drug Descovy to be used as a ...